IRBP, Interphotoreceptor Retinoid Binding Protein Fragment
- Cat.Number : AS-60183-1
- Manufacturer Ref. :
-
Availability :
In stock
This 20-residue peptide, a major pathogenic T-cell epitope (161–180), is present in the first homologous repeat of the interphotoreceptor retinoid binding protein peptide (IRBP). It has been shown to induce posterior uveitis (EAU).
Specifications
Chemistry | |
Sequence one letter code |
|
---|---|
Sequence three letter code |
|
Molecular Formula |
|
Molecular Mass/ Weight |
|
Modification | |
Conjugation |
|
Quantity & Purity | |
Purity |
|
Storage & stability | |
Form |
|
Storage Conditions |
|
Activity | |
Biomarker Target | |
Research Area | |
Sub-category Research Area | |
Usage |
|
Source | |
Source / Species |
|
Downloads
You may also be interested in the following product(s)



Citations
Low dose rapamycin exacerbates autoimmune experimental uveitis.
Plos One . 2012 May 04 ; 7(5) e36589 | DOI : 10.1371/journal.pone.0036589
- Z. Zhang
Role of DAF in protecting against T-cell autoreactivity that leads to experimental autoimmune uveitis.
Invest Ophthalmol Vis Sci. . 2009 May 14 ; 50(8) 3778 | DOI : 10.1167/iovs.08-3264
- F. An
Autoimmune uveitis elicited with antigen-pulsed dendritic cells has a distinct clinical signature and is driven by unique effector mechanisms: initial encounter with autoantigen defines disease phenotype.
J Immunol. . 2007 May 01 ; 178(9) 5578 | DOI : 10.4049/jimmunol.178.9.5578
- Jung Tan
References
Antigen/MHC Class II/Ig Dimers for Study of Uveitogenic T Cells: IRBP p161–180 Presented by both IA and IE Molecules
Invest Ophthalmol Vis Sci . 2005 Oct 01 ; 46(10) 3769 | DOI : https://doi.org/10.1167/iovs.05-0187
- Z. Karabekian
- et al
Identification of a major pathogenic epitope in the human IRBP molecule recognized by mice of the H-2r haplotype
Invest Ophthal Vis Sci . 1995 May 01 ; 36(5) 946 | DOI : 7706044
- P. Silver
- et al
Immunoregulatory Role of Ocular Macrophages: The Macrophages Produce RANTES to Suppress Experimental Autoimmune Uveitis
J Immunol . 2003 Sep 15 ; 171(5) 2652 | DOI : https://doi.org/10.4049/jimmunol.171.5.2652
- K. Sonoda
- et al
Transgenic Expression of a Soluble Complement Inhibitor Decreases the Incidence and Severity of Murine Experimental Autoimmune Uveitis
ARVO Meeting Abstracts . 2002 Dec 01 ; 43(13) 2281
- RW. Read
- SR. Barnum